Delivery Order SPE2DB22D2206-SPE2DB24FHZ40

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,427.17 firm-fixed-price delivery order is for the supply of SIMBRINZA 1%-0.2% eye drops (8 ml) and has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,759.58 firm fixed price contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with a completion date of April 26, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Simbrinza 1%-0.2% eye drops. The $1,356.52 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,117.10, is for the procurement of Simbrinza 1%-0.2% eye drops, a medical product used in the treatment of various eye conditions. The contract has an ultimate completion date of April 19, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,181.01, is for the delivery of Simbrinza 1%-0.2% eye drop solution in 8ml bottles. This is a firm fixed-price delivery order contract with a completion date of March 7, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
This federal contract award, with ID SPE2DX15D3201|SPE2DX24F3H9Q, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,252.77 firm fixed-price delivery order is for the supply of 4565778913 SIMBRINZA 1%-0.2% eye drops (8 mL) to support military treatment facilities and federal healthcare programs. The contract has no set-aside designation and will be completed by September 13, 2024. Amerisourcebergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SIMBRINZA 1%-0.2% eye drops in 8 milliliter vials. The contract has a total ceiling value of $1,485.86 and an ultimate completion date of September 13, 2023. This order is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
The Defense Logistics Agency (DLA) awarded a $3,496.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Cencora, Inc. The contract is for the supply of Bromsite 0.075% eye drops, a specialty medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of 0.5% eye drop lubricant, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,209.60 firm-fixed-price delivery order has a completion date of December 3, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,182.71 to Amerisourcebergen Drug Corp's Corporate Office Division to supply a pharmaceutical product described as "4564943795 ! XDEMVY 0.25% DROP 10ML". This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHZ40
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,053.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of SIMBRINZA 1%-0.2% eye drops. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support the Department of Defense (DoD) worldwide. The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/27/24, 9:27 AM